(10-331) Comparative Thrombotic Risk Following Administration of Andexanet Alfa Versus Four-Factor Prothrombin Complex Concentrate in Anticoagulant Reversal of Factor Xa Inhibitors
Wednesday, December 10, 2025
11:00 AM - 12:00 PM
Location: Bayside A, Level 1
Residency Program: Touro Infirmary Residency Program Type: PGY1 (Pharmacy) Residency Program Location: Louisiana
